![]()
1. Summary Information
|
|
|
Country |
|
|
Company Name |
Vin Biotech Systems Limited |
Principal Name 1 |
Mr. Jayalkshmi Viswanathan |
|
Status |
Moderate |
Principal Name 2 |
Mr. Viswanthan Praveen Shanmugam |
|
|
|
Registration # |
18-030366 |
|
Street Address |
No. 2, 2nd |
||
|
Established Date |
02.03.1995 |
SIC Code |
-- |
|
Telephone# |
91-44-64562736/ 64562737 |
Business Style 1 |
Manufacturer |
|
Fax # |
91-44-22391239 |
Business Style 2 |
Supplier |
|
Homepage |
Product Name 1 |
Fetal
|
|
|
# of employees |
Not Available |
Product Name 2 |
Doppler |
|
Paid up capital |
RS.
2,393,400/- |
Product Name 3 |
Fetal
Heart Rate |
|
Shareholders |
Directors or relatives of directors
(82.92%) Others (17.08%) |
Banking |
UCO Bank |
|
Public Limited Corp. |
NO |
Business Period |
16 Years |
|
IPO |
NO |
International Ins. |
- |
|
Public |
NO |
Rating |
B (29) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
-- |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2010 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
7,325,000 |
Current Liabilities |
2,911,000 |
|
Inventories |
2,865,000 |
Long-term Liabilities |
4,317,000 |
|
Fixed Assets |
788,000 |
Other Liabilities |
0 |
|
Deferred Assets |
0 |
Total Liabilities |
7,228,000 |
|
Invest& other Assets |
0 |
Retained Earnings |
1,357,000 |
|
|
|
Net Worth |
3,750,000 |
|
Total Assets |
10,978,000 |
Total Liab. & Equity |
10,978,000 |
|
Total Assets (Previous Year) |
9,078,000 |
|
|
|
P/L Statement as of |
31.03.2010 |
(Unit: Indian Rs.) |
|
|
Sales |
20,471,000 |
Net Profit |
891,000 |
|
Sales(Previous yr) |
26,177,000 |
Net Profit(Prev.yr) |
535,000 |
|
Report Date : |
03.09.2011 |
IDENTIFICATION DETAILS
|
Name : |
VIN BIOTECH SYSTEMS LIMITED |
|
|
|
|
Registered
Office : |
No. 2, 2nd |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2010 |
|
|
|
|
Date of
Incorporation : |
02.03.1995 |
|
|
|
|
Com. Reg. No.: |
18-030366 |
|
|
|
|
Paid-Up Capital
: |
Rs. 2.393 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24294TN1995PLC030366 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
CHEV05066F |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company. |
|
|
|
|
Line of Business
: |
Manufacturer
and Supplier of Fetal, Doppler, Fetal Heart Rate and Heart Rate Monitor. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B (29) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 15000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Sow but Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having moderate track. Trade
relations are reported as fair. Business is active. Payments are reported to
be slow but correct. The company can be considered for business dealings with some caution. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office : |
No. 2, |
|
Tel. No.: |
91-44-64562736/ 64562737 |
|
Fax No.: |
91-44-22391239 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory 1 : |
No. 1/538 (Old No. 1/462), Muthamizil Nagar, Hills Colonyl, Vandalur,
Chennai-600045, Tamilnadu, India |
|
Tel. No.: |
91-44-65462737/64562736 |
|
Fax No.: |
91-44-22391281/22391239 |
DIRECTORS
As On 30.09.2010
|
Name : |
Mr. Jayalkshmi Viswanathan |
|
Designation : |
Whole Time Director |
|
Address : |
No. 2, IInd Cross Street, MES
Road, Tambaram East, Chennai – 600059, Tamilnadu, India |
|
Date of Birth/Age : |
10.05.1958 |
|
Date of Appointment : |
02.03.1995 |
|
DIN No.: |
01676006 |
|
|
|
|
Name : |
Mr. Viswanthan Praveen Shanmugam |
|
Designation : |
Whole Time Director |
|
Address : |
No. 2, IInd Cross Street, MES
Road, Tambaram East, Chennai – 600059, Tamilnadu, India |
|
Date of Birth/Age : |
08.01.1986 |
|
Date of Appointment : |
02.02.2004 |
|
DIN No.: |
01676030 |
|
|
|
|
Name : |
Mr. Vinodhini Pavanasam Shanmugam |
|
Designation : |
Whole Time Director |
|
Address : |
No. 2, IInd Cross Street, MES
Road, Tambaram East, Chennai – 600059, Tamilnadu, India |
|
Date of Birth/Age : |
15.05.1987 |
|
Date of Appointment : |
02.01.2009 |
|
DIN No.: |
02532208 |
|
|
|
|
Name : |
Mr. Pavanasam Shanmugam |
|
Designation : |
Managing Director |
|
Address : |
No. 2, IInd Cross Street, MES Road,
Tambaram East, Chennai – 600059, Tamilnadu, India |
|
Date of Birth/Age : |
09.06.1955 |
|
Date of Appointment : |
02.03.1995 |
|
DIN No.: |
01880477 |
KEY EXECUTIVES
|
Name : |
Mr. K. V. Srinivasan |
|
Designation : |
Practicing Company Secretary |
|
Address: |
Flat No. F, Second Floor, Marutham Kurinji Apartments, 12A,
Nedunchezhian Street, Vijayalakshmipuram, Ambattur, Chennai – 600053,
Tamilnadu, India |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 30.09.2010
|
Names of Shareholders |
|
No. of Shares |
|
Ajeet Singh R |
|
100 |
|
Devendra Kumar Gandhi |
|
2000 |
|
Ganesh P |
|
2850 |
|
Ganeshlal K Jain |
|
1000 |
|
Hemavathi G. |
|
1600 |
|
Jayalakshmi V |
|
103100 |
|
Jayaraman P |
|
4960 |
|
Kumar K Jointly R. Mangalakshmi |
|
3100 |
|
Rajam P |
|
3130 |
|
Rajkumar P |
|
3540 |
|
Sankarapandian S Jointly S. Mookammal |
|
1000 |
|
Sankarapandian V |
|
3450 |
|
Satyadevi A |
|
2000 |
|
Shani P |
|
80670 |
|
Uma S |
|
1800 |
|
Viswanath Praveen |
|
8520 |
|
Veen Devendra Gandhi |
|
1000 |
AS ON 30.09.2010
|
Category |
|
Percentage |
|
Directors or relatives of directors |
|
82.92 |
|
Others |
|
17.08 |
|
Total
|
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer
and Supplier of Fetal, Doppler, Fetal Heart Rate and Heart Rate Monitor. |
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Bankers : |
·
UCO Bank - Selaiyur Branch, 3/151l, Velachery Road,
East Tambaram, Chennai-600059, Tamilnadu, India |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
P. Venkata Satishkumar and Associates Chartered Accountant |
|
Address : |
S-11 SSR Pankajam Enclave, II Floor, No. 24, Arunchalam Road,
Saligramam, Chennai – 600093, Tamilnadu, India |
|
Tel. No.: |
91-44-23761430 |
|
Mobile No.: |
91-9841288873 |
|
E-mail : |
|
|
Pan No.: |
AKRPS5780L |
CAPITAL STRUCTURE
AS ON 31.03.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
300000 |
Equity Shares |
Rs.10/- each |
Rs.3.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
239340 |
Equity Shares |
Rs.10/- each |
Rs.2.393
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
2.393 |
2.393 |
2.278 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.115 |
|
|
3] Reserves & Surplus |
1.357 |
0.802 |
0.543 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
3.750 |
3.195 |
2.936 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
3.845 |
0.000 |
1.431 |
|
|
2] Unsecured Loans |
0.472 |
1.462 |
0.928 |
|
|
TOTAL BORROWING |
4.317 |
1.462 |
2.359 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
8.067 |
4.657 |
5.295 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
0.788 |
0.709 |
0.824 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.087 |
|
|
DEFERRED TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
2.865
|
1.741
|
3.105 |
|
|
Sundry Debtors |
2.890
|
3.578
|
1.975 |
|
|
Cash & Bank Balances |
0.488
|
1.885
|
0.182 |
|
|
Other Current Assets |
0.000
|
0.000
|
0.000 |
|
|
Loans & Advances |
3.947
|
1.166
|
0.484 |
|
Total
Current Assets |
10.190
|
8.370
|
5.746 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
1.488
|
2.810
|
0.867 |
|
|
Other Current Liabilities |
0.534
|
1.104
|
0.174 |
|
|
Provisions |
0.889
|
0.508
|
0.321 |
|
Total
Current Liabilities |
2.911
|
4.422
|
1.362 |
|
|
Net Current Assets |
7.279
|
3.948
|
4.384 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
8.068 |
4.657 |
5.295 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
20.471 |
26.177 |
13.034 |
|
|
|
Other Income |
0.106 |
0.131 |
0.159 |
|
|
|
TOTAL (A) |
20.577 |
26.308 |
13.193 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Goods Sold |
13.439 |
17.528 |
8.949 |
|
|
|
Employees cost and Benefits |
1.047 |
1.289 |
1.073 |
|
|
|
Administrative Expenses |
2.177 |
2.984 |
1.608 |
|
|
|
Marketing and Selling Expenses |
2.083 |
2.849 |
0.742 |
|
|
|
TOTAL (B) |
18.746 |
24.650 |
12.372 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
1.831 |
1.658 |
0.821 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
0.355 |
0.292 |
0.386 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
1.476 |
1.366 |
0.435 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
0.154 |
0.149 |
0.145 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
1.322 |
1.217 |
0.290 |
|
|
|
|
|
|
|
|
|
Less |
TAX (I) |
0.431 |
0.682 |
0.158 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-I) (J) |
0.891 |
0.535 |
0.132 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
0.233 |
0.034 |
0.091 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
0.060 |
0.060 |
0.030 |
|
|
|
Proposed Dividend |
0.287 |
0.239 |
0.137 |
|
|
|
Dividend Tax |
0.049 |
0.037 |
0.022 |
|
|
BALANCE CARRIED
TO THE B/S |
0.728 |
0.233 |
0.034 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
NA |
0.122 |
N A |
|
|
TOTAL EARNINGS |
NA |
0.122 |
N
A |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Purchases |
NA |
11.935 |
NA |
|
|
TOTAL IMPORTS |
NA |
11.935 |
NA |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
3.72 |
2.30 |
NA |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
4.33
|
2.03
|
1.00 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
6.46
|
4.65
|
2.22 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
12.042
|
13.40
|
4.41 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.35
|
0.38
|
0.10 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
1.93
|
1.84
|
1.27 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
3.50
|
1.89
|
4.22 |
LOCAL AGENCY FURTHER INFORMATION
FORM 8:
|
This form is for |
Modification of charge
|
|||||||||||||||
|
Charge
identification number of the modified |
90283932 |
|||||||||||||||
|
Corporate
identity number of the company |
U24294TN1995PLC030366 |
|||||||||||||||
|
Name of the
company |
VIN BIOTECH
SYSTEMS LIMITED |
|||||||||||||||
|
Address of the registered
office or of the principal place of
business in |
No. 2, |
|||||||||||||||
|
Type of charge |
Book Debts Movable Property Floating Charge |
|||||||||||||||
|
Particular of charge
holder |
UCO Bankl, Selaiyur Branch, 3/151l, Velachery Road, East Tambaram,
Chennai-600059, Tamilnadu, India |
|||||||||||||||
|
Nature of
description of the instrument creating or modifying the charge |
1) Hypothecation
of goods and book debts. 2) Hypothecation of
goods. |
|||||||||||||||
|
Date of
instrument Creating the charge |
08.05.2009 |
|||||||||||||||
|
Amount secured by
the charge |
Rs. 10.000
Millions |
|||||||||||||||
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest Cash Credit :
12.50% p.a. with monthly rests. Terms of
Repayment Cash Credit : On
demand by the Bank, the Borrower shall pay the Bank the balance then due to
the Bank on the Cash Credit Account together with all further interest at the
agreed rate. Margin Cash credit - 25%
on stocks and 40% on book debts (upto 90days). Bank guarntee -
25% in cash/DULE discharged FDRS with lien noted in favour of the bank. Letter of credit
- 25% at the time of issue of ILC/FLC by way of FDR with lien noted in favour
of the bank. Others (Rs. In Millions)
|
|||||||||||||||
|
Short particulars
of the property charged |
Hypothecation by
way of FIRST CHARGE in favour of the Bank -- all stocks of
Bio Chemicals, medical equipments etc stored at No.1/462, Muthamizh Nagar,
Hills Colony, Vandalur Chennai - 600 048. The existing security
already offered shall continue to secure the Charge |
|||||||||||||||
|
Date of latest
modification prior to the present modification |
26.12.2007 |
|||||||||||||||
|
Particulars of
the present modification |
The amount
secured by charge has been modified from Rs.3.500 Millions to Rs.10.000
Millions All other terms
and conditions of the original charge and subsequent modification remains the
same |
FIXED ASSETS:
·
Furniture and Fittings
·
Plant and Machinery
·
Air Conditioner
·
Office Equipments
·
Computer
·
Pager
·
Tools and Dies
·
Suzuki Fiero- Bike
·
T.V S-50- Moped
·
Cycles
·
TVS Champ
·
Vacant Land
AS PER WEBSITE
PROFILE:
Subject was started in the year 1990 by a team of
technocrats. The Aim of the company is to bridge the gap between the
availability of quality medical equipments and their demand in the medical
fraternity. The company has three Integrations namely,
·
Outsourcing
·
Researching and
·
Distribution
The success of the company has been due to what more they
pack other than the contents,
·
Quality,
·
Reliability and
·
Value for money.
Subject outsources, researches and distributes devices used in Obstetrics and Gynaecology, Anesthesiology, and Oncology (Gynaecologic). While outsourcing, the reputation of the manufacturer, the quality of the products and the price are genuinely taken into consideration. They outsource products from any corner of the world provided the product outsourced meets there stringent outsourcing norms.
NEWS:
·
Vin Biotech has been found to comply to the Quality
Management System Standard NS-EN ISO 9001:2000 Certified Company.
·
NS-EN ISO 9001:2000 Certified Company - This
certificate is valid for the following products or service range of trading and
servicing of medical electronic equipments like patient monitor, CTG, ECG, TCD,
Ultra Sound Scanner and related products.
·
Vin Biotech has been awarded a NSIC - CRISIL rating
of SE 3B on 09.04.2009.
·
Vin Biotech launches war on cervical cancer, an
US-FDA approved state of the art cervical cancer screening system from
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.59 |
|
|
1 |
Rs.71.42 |
|
Euro |
1 |
Rs.61.10 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
3 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
3 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
29 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.